文献速递慢性肾脏病肾小球疾病

改变骨髓来源巨噬细胞命运可改善小鼠单侧输尿管梗阻模型中的肾纤维化

Fate alteration of bone marrow-derived macrophages ameliorates kidney fibrosis in murine model of unilateral ureteral obstruction.
PubMed 文献 · Nephrol Dial Transplant · 2019-01-01

本研究在小鼠单侧输尿管梗阻(UUO)模型中,通过抑制β-catenin/TCF信号增加β-catenin/Foxo1,减少骨髓来源巨噬细胞的巨噬细胞-肌成纤维细胞转分化(MMT)及炎性细胞因子产生,从而减轻肾纤维化。结果表明,改变骨髓来源巨噬细胞命运可同时抑制TGF-β的促纤维化作用并增强其抗炎作用。

要点

  • 抑制β-catenin/TCF可增加β-catenin/Foxo1,减少骨髓来源巨噬细胞MMT。
  • 该干预减少炎性细胞因子产生,并减轻UUO模型肾纤维化。
  • 改变巨噬细胞命运可让TGF-β发挥抗炎和抗纤维化双重作用。

核心结论

  • 将β-catenin从TCF转向Foxo1介导的转录,不仅能抑制TGF-β的促纤维化效应,还能增强其抗炎作用,从而减少炎症和纤维化。

研究设计与样本

  • 在EGFP骨髓嵌合小鼠中建立单侧输尿管梗阻(UUO)肾纤维化模型。
  • 通过抑制β-catenin/TCF(ICG-001联合TGF-β1处理)重定向TGF-β信号,增加β-catenin/Foxo1。
  • 用流式细胞术检测UUO肾脏GFP+F4/80+α-SMA+细胞,用免疫荧光染色检测体外骨髓来源巨噬细胞,用ELISA分析炎性及抗炎细胞因子。

主要发现

  • ICG-001联合TGF-β1处理增加β-catenin/Foxo1。
  • 该处理减少骨髓来源巨噬细胞的MMT和炎性细胞因子产生。
  • 该处理减轻UUO模型中的肾纤维化。

临床怎么用

  • 靶向β-catenin/TCF与β-catenin/Foxo1平衡可能成为减轻肾纤维化的治疗策略。
  • 骨髓来源巨噬细胞的MMT可作为抗纤维化干预的潜在靶点。

局限性

  • 研究为小鼠UUO模型,结论外推至人类慢性肾脏病需谨慎。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Renal fibrosis is a key pathological feature and final common pathway leading to end-stage kidney failure in many chronic kidney diseases. Myofibroblast is the master player in renal fibrosis. However, myofibroblasts are heterogeneous. Recent studies show that bone marrow-derived macrophages transform into myofibroblasts by transforming growth factor (TGF)-β-induced macrophage-myofibroblast transition (MMT) in renal fibrosis. METHODS: TGF-β signaling was redirected by inhibition of β-catenin/T-cell factor (TCF) to increase β-catenin/Foxo in bone marrow-derived macrophages. A kidney fibrosis model of unilateral ureteral obstruction was performed in EGFP bone marrow chimera mouse. MMT was examined by flow cytometry analysis of GFP+F4/80+α-SMA+ cells from unilateral ureteral obstruction (UUO) kidney, and by immunofluorescent staining of bone marrow-derived macrophages in vitro. Inflammatory and anti-inflammatory cytokines were analysis by enzyme-linked immunosorbent assay. RESULTS: Inhibition of β-catenin/TCF by ICG-001 combined with TGF-β1 treatment increased β-catenin/Foxo1, reduced the MMT and inflammatory cytokine production by bone marrow-derived macrophages, and thereby, reduced kidney fibrosis in the UUO model. CONCLUSIONS: Our results demonstrate that diversion of β-catenin from TCF to Foxo1-mediated transcription not only inhibits the β-catenin/TCF-mediated fibrotic effect of TGF-β, but also enhances its anti-inflammatory action, allowing therapeutic use of TGF-β to reduce both inflammation and fibrosis at least partially by changing the fate of bone marrow-derived macrophages.

来源:Nephrol Dial Transplant,查看原文。版权归原作者所有。

引用

  1. Yang Y, Feng X, Liu X, et al. Fate alteration of bone marrow-derived macrophages ameliorates kidney fibrosis in murine model of unilateral ureteral obstruction. Nephrol Dial Transplant. 2019. PMID: 30590718. doi:10.1093/ndt/gfy381

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。